Teva Pharmaceutical Industries Ltd
Close on Nov 17, 2026Market cap $49.66BP/E 71.0Yield –
Teva Pharmaceutical Industries Free Cash Flow (Teva Non-GAAP Definition) by Quarter
Free Cash Flow (Teva Non-GAAP Definition) ($M)
Teva Pharmaceutical Industries Free Cash Flow (Teva Non-GAAP Definition): $495M in Q3 2026, down 3.9% from a year earlier.
Where the Q3 2026 figure comes from
“|| Free cash flow | $ | 495 | $ | 515”
Source: Form 8-K Earnings Release (0001171843-26-007054) ↗
Operating cash flow plus beneficial interest collected in exchange for securitized trade receivables and proceeds from divestitures/asset sales, less cash capital investments.
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up free Cash Flow (Teva Non-GAAP Definition)
Cite this data
StockData. (2026). Teva Pharmaceutical Industries Free Cash Flow (Teva Non-GAAP Definition) ($M), quarterly Q1 2018–Q3 2026 [Data set]. Compiled from Teva Pharmaceutical Industries SEC filings and investor materials. https://stockdatahq.com/stocks/teva/kpis/fcf-total
See every metric in the Teva Pharmaceutical Industries KPI table. Data updated Nov 10, 2026.
See a number that looks wrong?